rapid
progress
diseas
biomark
discoveri
increas
need
robust
detect
technolog
past
sever
year
design
mani
immunoaffin
reagent
focus
lower
cost
improv
specif
also
promot
stabil
antibodi
fragment
scfv
long
display
surfac
yeast
phage
librari
select
howev
stabl
product
fragment
present
challeng
hamper
widespread
use
diagnost
membran
cell
wall
protein
similarli
suffer
stabil
problem
solubil
nativ
environ
recent
cell
envelop
composit
maintain
membran
protein
nativ
nativelik
lipid
environ
improv
stabil
develop
cell
envelop
composit
approach
adapt
toward
stabil
antibodi
fragment
retain
nativ
cell
wall
environ
new
class
immunoaffin
reagent
develop
maintain
antibodi
fragment
attach
yeast
cell
wall
herein
review
recent
strategi
incorpor
cell
wall
fragment
function
scfv
design
easi
product
maintain
specif
stabil
use
simpl
detect
platform
cell
wall
base
antibodi
fragment
globular
structur
heterogen
size
fragment
rang
ten
hundr
nanomet
size
fragment
appear
retain
activ
immobil
onto
biosensor
surfac
specif
sensit
detect
pathogen
antigen
quickli
econom
gener
yeast
display
librari
store
lyophil
room
temperatur
year
littl
effect
stabil
new
format
scfv
provid
stabil
simpl
lowcost
manner
toward
use
scfv
biosensor
applic
product
pan
antibodi
cell
wall
composit
also
extrem
facil
enabl
rapid
adopt
stabl
inexpens
affin
reagent
emerg
infecti
threat
protein
wide
use
biomark
target
medicin
protein
target
character
affin
binder
product
proteom
immunosensor
focu
extens
research
develop
protein
antibodi
natur
produc
within
biolog
environ
howev
mani
biotechnolog
applic
requir
biomolecul
solubil
studi
use
problemat
mani
biomolecul
often
lose
stabil
denatur
lose
quaternari
tertiari
secondari
structur
introduc
foreign
nonn
environ
membranebound
protein
particular
wide
exploit
druggabl
target
difficult
studi
solubil
target
due
protein
conform
chang
absenc
stabil
lipid
cell
wall
environ
similarli
synthet
recombin
antibodi
produc
eukaryot
prokaryot
product
system
commonli
lose
stabil
especi
origin
display
librari
mani
strategi
develop
overcom
stabil
issu
particularli
promis
cell
envelop
composit
stabil
protein
recombin
antibodi
nativ
nativelik
environ
recombin
antibodi
fragment
promis
class
protein
captur
reagent
pois
complement
replac
complet
fulllength
monoclon
antibodi
mab
immunosensor
fragment
show
ident
specif
toward
target
antigen
parent
fulllength
mab
also
ad
flexibl
engin
fragment
antigen
bind
site
allow
custom
product
reagent
sought
affin
trait
furthermor
antibodi
fragment
rapidli
isol
librari
antibodi
fragment
gene
use
variou
display
technolog
renew
produc
eukaryot
prokaryot
product
system
follow
scaleup
manufactur
reduc
product
cost
recent
develop
antibodi
librari
biopan
method
util
whole
cell
select
ensur
recombin
membranebound
protein
maintain
nativ
conform
antibodi
select
one
common
type
antibodi
fragment
singlechain
variabl
fragment
scfv
recombin
polypeptid
compos
lightchain
variabl
v
l
domain
connect
flexibl
hydrophil
peptid
heavychain
variabl
v
h
domain
kda
monoval
protein
possess
compar
specif
sensit
parent
mab
due
lack
constant
domain
fc
region
capabl
superior
perform
imag
diagnost
agent
furthermor
product
pipelin
recombin
immunoaffin
reagent
could
potenti
reduc
problem
hamper
tradit
fulllength
mab
manufactur
batch
batch
variabl
slow
drift
qualiti
immunoaffin
reagent
time
despit
advantag
mani
solubl
express
scfv
suffer
stabil
problem
necessit
new
design
strategi
produc
stabl
protein
captur
agent
membran
cell
wall
protein
similarli
suffer
stabil
problem
solubil
nativ
membran
environ
biolog
nanocontain
strategi
develop
stabil
membran
protein
maintain
nativ
nativelik
lipid
environ
protein
studi
approach
stabil
surfac
protein
nativ
environ
adapt
stabil
recombin
antibodi
fragment
yeast
display
librari
scfv
stabil
maintain
nativ
cell
wall
environ
yeast
display
librari
select
yeast
cell
wall
compris
semirigid
polysaccharidelipid
protein
matrix
provid
structur
rigid
cell
protect
physic
stress
scaffold
surfac
protein
although
mani
differ
cell
membran
yeast
cell
wall
cell
envelop
approach
util
principl
stabil
molecul
nativ
nativelik
environ
avoid
issu
solubil
plagu
protein
antibodi
protein
studi
herein
highlight
biolog
composit
maintain
membran
protein
scfv
stabil
retain
nativ
nativelik
environ
design
easi
product
maintain
specif
stabil
use
simpl
detect
platform
figur
membran
protein
util
research
diagnost
industri
wide
exploit
drug
target
numer
fdaapprov
experiment
small
molecul
drug
protein
biolog
bind
membran
protein
mab
largest
class
protein
biolog
drug
indic
includ
cancer
inflammatori
diseas
although
sever
methodolog
util
recombin
dna
technolog
ie
hybridoma
technolog
antibodi
display
technolog
produceselect
mab
bind
solubl
protein
gener
use
mab
bind
surfac
protein
use
display
technolog
much
challeng
surfac
protein
gener
extens
hydrophob
domain
embed
lipid
bilay
andor
polysaccharid
cell
wall
remov
environ
render
surfac
protein
poorli
solubl
prone
aggreg
misfold
denatur
introduc
pure
aqueou
environ
solubil
surfac
protein
especi
membran
protein
achiev
use
deterg
howev
deterg
deactiv
protein
denatur
structur
difficult
remov
requir
solubl
extracellular
domain
protein
may
express
gener
use
howev
may
chang
conform
reli
immobil
within
lipid
bilay
cell
wall
structur
whole
intact
cell
overexpress
receptorofinterest
use
variou
neg
biopan
strategi
need
employ
reduc
nonspecif
bind
studi
membran
protein
one
strategi
studi
util
membran
protein
maintain
nativ
state
creat
artifici
cell
envelop
composit
mimic
nativ
lipid
bilay
environ
membran
sever
exampl
manipul
lipid
bilay
stabil
membran
protein
detail
tabl
nanodisc
one
approach
creat
artifici
cell
envelop
composit
use
nanodisc
discoid
nanoparticl
form
synthet
lipid
surround
belt
consist
amphipath
domain
protein
call
membran
scaffold
protein
msp
target
membran
protein
transient
solubil
deterg
presenc
phospholipid
encircl
msp
deterg
remov
target
membran
protein
simultan
assembl
phospholipid
discoid
bilay
size
control
length
msp
figur
standard
method
selfassembl
mp
nanodisc
shown
figur
rout
deterg
solubil
purif
target
mp
green
mix
membran
scaffold
protein
msp
blue
lipid
correct
stoichiometri
follow
deterg
remov
incub
hydrophob
bead
often
howev
mp
stabl
deterg
extend
time
need
purif
altern
figur
rout
start
membran
tissu
directli
solubil
excess
lipid
scaffold
protein
rapid
deterg
remov
result
placement
target
mp
green
togeth
mp
gray
tissu
nanodisc
subsequ
purif
often
affin
tag
perform
target
stabil
nanodisc
environ
latter
rout
also
use
gener
solubl
mp
librari
faith
repres
mp
start
tissu
result
nanodisc
keep
protein
solut
provid
stabil
retain
membran
protein
nativelik
phospholipid
bilay
environ
nanodisc
immobil
onto
surfac
allow
kinet
studi
drug
bind
determin
carri
solubl
molecul
incorpor
membran
protein
phage
display
select
also
perform
use
nanodiscbound
protein
target
select
highqual
synthet
reagent
bind
membran
protein
nativelik
lipid
environ
recent
incorpor
therapeut
antibodi
nanodisc
also
propos
critic
factor
success
form
nanodisc
reli
ensur
correct
stoichiometri
phospholipid
msp
target
protein
incorrect
stoichiometri
rapid
highthroughput
method
direct
evolut
stabil
solubl
protein
divers
librari
million
physic
encapsul
protein
provid
protect
deterg
membran
solubil
prevent
diffus
protein
nanocontain
protein
requir
link
fusion
molecul
molecular
weight
greater
kda
ideal
rang
ph
potenti
aggreg
low
ph
dissolut
nanocapsul
high
ph
lipid
msp
target
protein
result
aggreg
vari
nondiscoid
structur
difficult
separ
character
isol
desir
nanolipoprotein
particl
nanodisc
method
also
requir
membran
protein
assembl
detergentsolubil
state
therefor
method
work
target
protein
alreadi
aggreg
solubl
protein
alreadi
aqueou
solut
like
inact
smalp
styren
maleic
acid
lipid
particl
smalp
allow
membran
protein
remain
stabil
use
simpl
organ
polym
sma
copolym
use
directli
extract
protein
membran
lipid
nanoparticl
call
smalp
smalp
contain
central
lipid
bilay
support
outer
annulu
sma
polym
approach
extract
membran
protein
place
nativ
lipid
environ
similar
nanodisc
method
detail
howev
unlik
nanodisc
smalp
approach
requir
membran
protein
presolubil
deterg
insert
lipid
nanoparticl
smalp
structur
stabil
intercal
hydrophob
styren
group
acyl
chain
lipid
bilay
wherea
hydrophil
maleic
acid
group
present
solvent
encapsul
bilay
retain
mani
physic
properti
parent
membran
includ
lipid
mixtur
structur
organ
phase
behavior
although
method
effect
preserv
membran
protein
nativ
lipid
envelop
limit
need
taken
account
disc
shape
smalp
maximum
nomin
diamet
nm
correspond
molecular
mass
less
kda
therefor
protein
larg
fit
within
limit
unlik
solubil
format
smalp
also
requir
ph
mean
downstream
experi
also
need
carri
ph
maintain
smalp
structur
sma
polym
effect
chelat
dival
cation
mg
ca
chelat
also
insolubl
downstream
experi
requir
high
concentr
dival
cation
nm
could
disrupt
smalp
dival
cation
found
membran
protein
bind
nucelotid
abc
transport
atpas
howev
experi
could
adjust
lower
concentr
nucelotid
preserv
smalp
integr
still
maintain
nativ
level
membran
protein
activ
work
around
limit
lentiviru
lentiviru
particl
use
present
cell
membran
protein
surfac
allow
ligand
interact
studi
optic
biosensor
use
condit
resembl
nativ
vivo
environ
bud
cell
surfac
virus
pull
away
membran
fragment
bear
protein
lipid
environ
author
took
advantag
process
present
gproteincoupl
receptor
gpcr
protein
surfac
lentivir
particl
gpcr
protein
found
incorpor
virion
easili
purifi
attach
biosensor
surfac
method
elimin
need
deterg
solubil
gpcr
protein
thu
allow
stabl
environ
conduct
kinet
studi
studi
show
gpcr
could
stabil
lentivir
surfac
howev
addit
experi
requir
demonstr
univers
approach
toward
display
stabil
membran
protein
protein
interact
captur
studi
furthermor
lentivir
particl
applic
far
limit
kinet
studi
use
surfac
plasmon
reson
spr
readout
platform
lentivir
particl
posit
univers
membran
protein
stabil
platform
proof
compat
biosensor
platform
need
conduct
given
lenivir
particl
typic
nm
like
amen
wide
rang
biosensor
platform
liposom
immobil
liposom
also
shown
promis
method
stabil
membran
protein
nativelik
environ
maintain
function
liposom
spheric
nanoparticl
unilamellar
multilamellar
structur
separ
encapsul
aqueou
interior
bulk
aqueou
solvent
lamella
liposom
compos
bilay
lipid
hydrophob
midplan
separ
two
aqueou
volum
interact
lipid
membran
protein
shown
promot
proper
orient
influenc
protein
function
method
membranebound
protein
purifi
nativ
membran
environ
reconstitut
liposom
comicel
encapsul
layer
serv
semiperm
barrier
retain
solubil
receptor
encod
plasmid
within
capsul
bind
function
receptor
molecul
e
capsul
contain
detergentst
gpcr
mutant
fluoresc
sort
popul
use
fac
f
genet
materi
recov
sort
capsul
g
use
either
identifi
desir
receptor
mutant
serv
templat
round
mutat
select
h
figur
purifi
membran
protein
excess
phospholipid
deterg
form
solut
lipidproteindeterg
lipiddeterg
micel
dialysi
dilut
adsorpt
common
reconstitut
method
method
work
reduc
concentr
deterg
critic
micel
concentr
reconstitut
method
disadvantag
dialysi
take
week
case
deterg
low
critic
micel
length
time
result
denatur
membran
protein
dilut
result
larg
volum
subsequ
lower
protein
downstream
experi
difficult
deterg
adsorpt
polystyren
bead
remov
deterg
effici
due
rapid
uncontrol
remov
denatur
protein
howev
new
promis
method
propos
aim
remov
limit
improv
yield
reduc
reconstitut
time
liposom
also
coencapsul
codeliv
multiples
drug
agent
coat
liposom
inert
hydrophil
polym
stealth
liposom
poli
ethylen
glycol
reduc
nonspecif
absorpt
henc
increas
circul
time
although
liposom
promis
stabil
platform
membran
protein
drug
deliveri
size
typic
nm
larg
unilamellar
vesicl
interfer
biosensor
surfac
henc
decreas
sensit
applic
requir
close
proxim
surfac
sensor
element
eg
spr
howev
size
limit
overcom
develop
planar
lipid
membran
construct
nm
size
rang
supportedlipid
bilay
hybrid
bilay
lipid
membran
polymercushion
membran
tether
membran
differ
planar
lipid
model
aim
mimic
cell
membran
structur
allow
membran
protein
retain
structur
integr
function
across
mani
protein
applic
particular
model
requir
use
solid
support
differ
lipid
composit
aim
provid
nativelik
environ
protein
studi
chess
cellular
highthroughput
encapsul
solubil
screen
chess
recent
develop
method
gener
detergentresist
contain
singl
cell
physic
enclos
detergentsolubil
integr
membran
protein
imp
allow
direct
select
detergentst
imp
divers
display
librari
figur
chess
encapsul
singl
escherichia
coli
e
coli
cell
librari
express
differ
g
proteincoupl
receptor
gpcr
variant
form
detergentresist
semiperm
nanocontain
contain
resist
solubil
deterg
allow
gpcr
solubil
situ
maintain
associ
protein
genet
inform
pore
size
nanocontain
control
permit
gpcr
ligand
permeat
also
allow
solubil
receptor
remain
within
nanocapsul
fluoresc
label
ligand
use
bind
gpcr
variant
insid
nanocontain
remain
activ
deterg
recent
chess
develop
evolv
stabl
solubl
protein
directli
protein
superfold
gfp
evolv
use
chess
becom
resist
deterg
includ
sodium
dodecyl
sulfat
high
temperatur
low
ph
allow
larg
librari
solubl
protein
directli
screen
stabil
condit
limit
remain
includ
requir
link
target
protein
fusion
molecul
molecular
weight
greater
kda
prevent
protein
diffus
nanocontain
although
lowph
condit
result
viabl
nanocapsul
mani
aggreg
suggest
optim
remain
sampl
prepar
reduc
exposur
time
maxim
select
viabl
solubl
protein
acid
condit
highph
condit
result
dissolut
nanocapsul
suggest
altern
nanocapsul
coat
would
requir
select
viabl
protein
highph
condit
current
chess
also
requir
fluoresc
readout
determin
protein
stabil
fluoresc
activ
cell
sort
fac
select
howev
fac
power
system
rapidli
sort
cell
coupl
chess
allow
direct
select
rare
mutat
infer
increas
protein
stabil
abnorm
cell
condit
togeth
method
demonstr
approach
use
cell
envelop
stabil
membran
protein
nativ
nativelik
lipid
environ
protein
studi
mammalian
membran
cell
use
composit
use
protein
cellular
studi
sever
studi
use
membran
fragment
mammalian
cell
fundament
studi
interact
toxin
absorpt
cancer
therapi
take
advantag
uniqu
structur
properti
cell
plasma
membran
similar
stealth
liposom
cell
membran
capsul
cmc
use
encapsul
chemotherapeut
drug
drug
typic
rapidli
clear
free
form
lack
cancer
cell
specif
synthet
nanoparticl
commonli
use
deliv
drug
recogn
immun
system
natur
approach
cmc
allow
drug
deliveri
evad
bodi
defens
mechan
due
structur
composit
cell
membran
protein
lipid
allow
good
biocompat
cmc
also
use
control
load
releas
encapsul
reagent
cmc
nontox
effect
minim
recognit
intern
macrophag
thu
evad
immun
attack
bodi
cmc
intrins
biocompat
function
drug
deliveri
releas
vehicl
cmc
form
tumor
cellderiv
microparticl
also
use
vector
deliv
chemotherapeut
drug
cellular
membran
microparticl
safer
selffriendli
reduc
toxic
ie
induc
autoimmun
micromet
size
much
larger
physiolog
capillari
gap
around
nm
prevent
micrometers
particl
reach
normal
tissu
caus
damag
applic
membran
composit
involv
use
mammalian
cellderiv
nativ
vesicl
novel
bioanalyt
reagent
allow
miniatur
receptorbas
assay
physiolog
condit
cultur
mammalian
cell
suitabl
recombin
express
provid
posttransl
modif
essenti
receptor
function
vesicl
cellsurfac
receptor
cytoplasm
protein
retain
origin
cellular
locat
orient
function
store
week
without
lose
function
integr
vesicl
could
use
univers
inexpens
bioanalyt
reagent
investig
cellular
signal
reaction
membran
fragment
composit
compris
polymer
core
nanoparticl
coat
bilay
red
blood
cell
rbc
membran
use
nanospong
absorb
cellular
damag
toxin
rbc
nanoparticl
absorb
neutral
rang
poreform
protein
toxin
potenti
result
improv
therapeut
outcom
togeth
mammalian
membran
fragment
technolog
demonstr
mimick
nativ
environ
benefici
drug
deliveri
cellular
studi
proteom
work
mammalian
membran
mani
benefit
includ
low
toxic
drug
deliveri
correct
orient
fragment
nanoparticl
import
maintain
biolog
perform
molecul
eg
recombin
antibodi
nativ
part
cell
eg
yeast
cell
wall
also
benefit
encapsul
nativ
nativelik
environ
protein
studi
numer
recombin
technolog
develop
select
affin
binder
either
larg
librari
polypeptid
antibodi
fragment
scfv
affin
binder
readili
isol
librari
display
use
variou
system
select
express
character
capabl
enabl
isol
antibodi
fragment
chosen
toward
particular
target
antigen
without
need
anim
immun
yeast
cell
display
introduc
develop
enhanc
affin
stabil
properti
affin
ie
affin
matur
stabil
express
protein
compat
flow
cytometri
yeast
clone
interest
isol
base
phenotyp
bind
fluoresc
label
antigen
antigenbind
yeast
rapidli
sort
use
fac
antigenbind
yeast
clone
select
librari
littl
week
elimin
need
subclon
express
purif
step
contrast
phage
display
wherein
phage
librari
pan
immobil
ligand
wash
elut
bulk
abil
visual
bind
real
time
highli
advantag
enabl
ongo
monitor
finetun
select
strategi
success
bind
phage
ribosom
display
pan
procedur
assess
final
wash
step
complet
bind
fraction
elut
propag
contrast
yeast
select
dynam
librari
incub
multipl
antigen
concentr
vari
condit
level
antigen
bind
assess
real
time
flow
cytometri
illustr
studi
publish
yeast
display
use
discoveri
character
novel
affin
reagent
larg
nonimmun
human
scfv
librari
previous
describ
advantag
fac
rapid
select
flow
cytometri
realtim
assess
bind
well
abil
develop
whole
yeast
flow
cytometr
detect
assay
demonstr
yeast
display
technolog
power
techniqu
creat
librari
antibodi
fragment
whole
yeast
cell
stabil
membran
protein
scfv
select
yeast
display
also
use
screen
antibodi
librari
membran
protein
nearn
conform
yeast
biopan
wherein
monolay
whole
cell
act
antigen
suggest
potenti
approach
typic
yeast
display
requir
use
solubl
antigen
librari
biopan
previous
discuss
pose
problem
attempt
select
antibodi
fragment
membran
protein
combin
yeast
surfac
display
directli
whole
cell
detergentsolubil
wholecel
lysat
potenti
solv
problem
allow
antibodi
librari
screen
membran
protein
nearn
conform
one
exampl
yeast
biopan
yeastdisplay
scfv
select
success
round
incub
mammalian
monolay
nonspecif
bound
yeast
remov
wash
yeast
biopan
method
later
use
isol
number
uniqu
scfv
bind
plasma
membran
protein
rat
brain
endotheli
cell
line
anoth
approach
employ
yeast
surfac
displaybas
screen
use
cell
lysat
solubl
antigen
sourc
detergentsolubil
membran
protein
form
cell
lysat
mix
scfvdisplay
yeast
result
mixtur
sort
use
fac
process
repeat
lead
enrich
yeast
clone
bound
desir
antigen
antibodi
fragment
elut
yeast
surfac
yeast
display
immunoprecipit
ydip
method
demonstr
effici
discoveri
novel
antibodytarget
combin
toward
membran
protein
stabil
wholecel
solubil
wholecel
lysat
strategi
scfv
stabil
limit
scfv
deriv
yeast
display
librari
perform
recombin
antibodylik
fragment
solut
yeast
phage
display
antibodi
fragment
select
affin
stabil
bound
surfac
result
fragment
possess
high
activ
surfac
often
lose
activ
solut
although
numer
exampl
scfv
use
success
immunoassay
mani
scfv
perform
unsatisfactorili
compar
fulllength
mab
due
stabil
issu
moreov
antibodi
fragment
typic
display
low
stabil
prone
aggreg
due
lack
interdomain
stabil
found
larger
antibodi
reagent
igg
fab
fragment
strategi
scfv
stabil
vari
method
detail
tabl
aggreg
resist
modifi
antigen
bind
site
recent
studi
aggregationresist
scfv
produc
introduc
neg
charg
amino
acid
antigen
bind
site
mutat
addit
aspartateor
glutamateenhanc
aggreg
resist
alter
local
charg
distribut
highli
specif
posit
irrespect
sequenc
divers
posit
mutant
v
h
v
l
domain
determin
highli
conserv
show
minim
impact
bind
superantigen
compar
nonmut
wildtyp
scfv
heat
consider
improv
superantigen
bind
compar
wildtyp
scfv
heat
perform
wildtyp
scfv
readili
aggreg
high
temperatur
howev
observ
mutant
scfv
mutat
allow
improv
express
purif
yield
product
therapeut
antibodi
fragment
howev
addit
work
requir
evalu
mutat
improv
solubl
fulllength
antibodi
similar
work
fulllength
antibodi
shown
mutat
introduc
specif
complementar
determin
region
cdr
fulllength
antibodi
also
increas
antibodi
solubl
decreas
aggreg
interestingli
introduc
glycan
antibodi
cdr
c
h
domain
found
increas
solubl
without
reduc
bind
affin
furthermor
glycan
type
found
affect
solubl
igg
express
yeast
mannoserich
glycan
found
resist
aggreg
igg
express
mammalian
cell
one
key
studi
demonstr
avoid
aggreg
hotspot
within
antibodi
requir
consider
static
antibodi
structur
consider
dynam
well
investig
use
molecular
simul
igg
identifi
aggregationpron
hydrophob
region
either
nativ
expos
expos
due
dynam
fluctuat
conform
chang
simul
model
solvent
exposur
everi
atom
antibodi
rel
aggreg
propens
amino
acid
calcul
simul
identifi
aggreg
hotspot
cdr
constant
domain
develop
simul
model
could
improv
identif
solubil
mutat
impact
bind
affin
modifi
net
antibodi
charg
anoth
method
increas
antibodi
solubl
without
mutat
cdr
increas
net
charg
antibodi
one
studi
scfv
supercharg
mutat
solventexpos
residu
charg
residu
polar
use
comput
program
research
select
charg
mutat
v
h
v
l
domain
scfv
predict
avoid
destabil
antibodi
fold
interestingli
found
posit
charg
scfv
remain
much
stabl
retain
high
bind
affin
heat
compar
neg
charg
scfv
wildtyp
scfv
observ
appli
singledomain
antibodi
dab
aggregationresist
dab
typic
net
neg
charg
due
acid
isoelectr
point
studi
underscor
need
better
understand
charg
residu
impact
aggreg
solubl
antibodi
antibodi
fragment
composit
stabil
achiev
keep
antibodi
fragment
anchor
display
host
eg
yeast
cell
wall
strategi
altern
standard
approach
solubil
scfv
prior
anchor
onto
surfac
importantli
approach
maintain
scfv
environ
select
function
thu
case
use
yeast
display
librari
advantag
use
fac
select
undermin
reengin
scfv
solubl
form
lyophil
wholecel
reagent
use
sandwich
assay
format
tradit
immunoglobulin
signal
antibodi
describ
recent
whole
yeast
cell
express
scfv
surfac
modifi
gold
bind
peptid
allow
simpl
costeffect
method
conjug
whole
yeast
cell
sensor
gold
substrat
wholecel
probe
lyophil
creat
stabl
reagent
requir
refriger
immedi
usabl
follow
rehydr
develop
improv
lyophil
storag
protocol
wholecel
found
shelf
life
lyophil
form
year
furthermor
flow
cytometri
immunofluoresc
microscopi
direct
assay
develop
use
wholecel
reagent
combin
common
laboratori
devic
howev
wholecel
reagent
insolubl
larg
mani
immunodiagnost
applic
moreov
requir
use
label
polyclon
monoclon
antibodi
detect
antigen
bind
particl
although
necessari
detect
antibodi
highli
specif
antigen
yeastscfv
reagent
confer
monoclon
specif
requir
tradit
animalderiv
detect
antibodi
dilut
benefit
use
nanos
yeast
cell
envelop
antibodi
composit
limit
wholecel
yeastscfv
address
mechan
fragment
wholecel
yeastscfv
nanos
yeast
cell
wall
piec
produc
cellfre
yeastscfv
affin
reagent
cell
wall
fragment
bear
display
scfv
figur
becom
enrich
bind
surfaceattach
tabl
comparison
scfv
stabil
strategi
scfv
stabil
strategi
advantag
disadvantag
aggreg
resist
modifi
antigen
bind
site
scfv
stabil
improv
creat
aggregationresist
mutant
modifi
antigen
bind
site
cumbersom
could
potenti
impact
antigen
bind
abil
b
modifi
net
antibodi
charg
cdr
left
unmodifi
impact
antigen
bind
abil
less
like
affect
requir
mutat
site
along
still
cumbersom
method
c
cell
envelop
composit
simpl
strategi
stabil
biomolecul
ie
scfv
limit
process
step
fragment
left
nativ
cell
envelop
environ
kept
intact
fragment
depend
applic
could
lyophil
longterm
storag
cell
surfac
allow
multipl
scfv
provid
multival
avid
effect
protein
captur
suit
applic
nativ
cell
wall
could
interfer
surround
environ
potenti
cell
fragment
aggreg
possibl
nonspecif
absorpt
fragment
size
optim
consider
biomolecul
ie
scfv
cellsurfac
heterogen
express
need
undertaken
antibodi
specif
scfv
epitop
tag
reagent
term
develop
new
format
prepar
scfv
potenti
substitut
fulllength
mab
demonstr
specif
advantag
wholecel
fragment
retain
stabil
function
select
yeast
surfac
display
use
express
scfv
cell
surfac
use
aagglutinin
system
develop
boder
wittrup
boder
wittrup
system
use
display
fusion
partner
disulfid
link
glycosylphosphatidylinositol
gpi
protein
name
coval
attach
yeast
cell
wall
figur
system
secur
fusion
protein
yeast
cell
wall
engin
scfv
ntermin
hemagglutinin
ha
ctermin
cmyc
epitop
tag
enabl
detect
affin
purif
fusion
protein
independ
ligandbind
characterist
scan
electron
microscopi
sem
transmiss
electron
microscopi
tem
atom
forc
microscopi
afm
use
character
structur
figur
specif
captur
immobil
ha
tag
use
ha
antibodi
conjug
highli
polish
anatom
flat
glass
substrat
sem
show
cluster
globular
particl
coat
substrat
surfac
figur
insolut
character
captur
onto
magnet
particl
via
ha
tag
gentli
elut
use
excess
ha
peptid
analyz
use
tem
figur
micrometers
aggreg
cluster
evid
suggest
work
prevent
aggreg
solut
need
consid
afm
immobil
onto
atom
flat
polish
glass
substrat
also
show
globular
particl
cover
sensor
surfac
novel
reagent
readili
select
yeast
scfv
antibodi
librari
figur
cell
wall
fragment
anchorag
may
constrain
scfv
secondari
tertiari
structur
year
need
simpli
fragment
use
mortar
pestl
resuspend
filter
size
use
syring
filter
use
directli
immunoassay
process
yeast
display
librari
product
take
week
minut
fac
select
recombin
product
elimin
step
requir
gener
antibodi
hold
scfv
configur
best
antigen
bind
cell
fragment
determin
globular
electron
microscopi
atom
forc
microscopi
afm
measur
figur
similarli
yeast
display
mammalian
cell
technolog
highlight
earlier
orient
protein
scfv
manipul
improv
display
function
properti
achiev
link
scfv
either
cterminu
anchor
protein
gener
mechan
fragment
use
mortar
pestl
filter
size
produc
yeast
cell
wall
fragment
vari
size
scfv
complex
remain
intact
cell
fragment
concentr
determin
use
protein
concentr
assay
base
measur
protein
present
yeast
cell
fragment
cell
fragment
size
control
use
size
exclus
filter
simpl
syring
pump
method
elimin
larger
fragment
nm
found
interfer
electrochemicalbas
biosensor
larger
size
fragment
may
exert
forc
solut
potenti
overcom
antiha
bond
captur
onto
biosensor
result
larger
cell
wall
fragment
becom
dislodg
biosensor
surfac
yeast
cell
envelop
antibodi
composit
biosens
applic
electrochem
approach
util
detect
antigen
bind
use
figur
sensit
approxim
pg
ml
use
fe
cn
redox
probe
farada
electrochem
imped
spectroscopi
fei
allow
detect
capacit
chang
labelfre
detect
biomolecul
probe
buildup
layer
biomateri
electrod
success
detect
captur
biomolecul
interest
observ
chang
capacit
interfaci
electrontransf
resist
electrod
randl
equival
circuit
imped
measur
present
form
nyquist
plot
real
imaginari
compon
includ
semicircl
region
lay
axi
follow
straight
line
figur
higher
frequenc
semicircl
portion
nyquist
plot
observ
correspond
electrontransferlimit
process
semicircl
diamet
directli
relat
electrontransf
resist
electrod
surfac
r
et
therefor
construct
immunosens
layer
antibodyantigen
complex
bind
observ
fei
chang
imped
electrod
surfac
electrolyt
solut
contain
redox
probe
eg
fe
cn
measur
form
r
et
figur
util
antigen
captur
agent
demonstr
specif
captur
pathogen
antigen
spike
biolog
matrix
compris
stool
addit
singl
pathogen
antigen
success
captur
previou
work
new
second
pathogen
antigen
type
test
respect
cognat
develop
consist
predict
could
routin
engin
captur
target
antigen
interest
addit
screenprint
gold
electrod
use
diagnost
platform
replac
gold
macroelectrod
previou
work
support
expect
util
pointofcar
diagnost
flexibl
demonstr
use
altern
readout
platform
surfaceenhanc
raman
scatter
ser
employ
duplex
antigen
detect
use
probe
figur
ser
nanoparticl
label
compris
nobl
metal
nanoparticl
coat
raman
report
molecul
identif
base
characterist
vibrat
raman
spectrum
compar
convent
immunoassay
base
electrochemistri
fluoresc
elisa
ser
number
advantag
first
multiplex
capabl
due
singl
laser
excit
result
narrowband
raman
spectral
signatur
wide
excit
wavelength
second
ser
amplifi
raman
signal
order
magnitud
provid
high
sensit
ser
also
provid
uniqu
spectral
fingerprint
signatur
analyt
allow
high
specif
scfv
immobil
onto
microfluid
chip
differ
channel
depend
scfv
target
type
figur
captur
antigen
detect
use
secondari
detect
antibodi
label
ser
particl
ser
label
provid
uniqu
spectra
use
distinguish
particl
one
anoth
use
raman
microspectromet
due
sensit
advantag
gain
ser
report
limit
detect
lod
reduc
pg
ml
altern
current
electrohydrodynam
acehd
platform
demonstr
rapid
captur
sensit
detect
target
antigen
togeth
less
min
acehd
field
charg
induc
within
electr
doubl
layer
electrod
experi
electr
bodi
forc
drive
bulk
fluid
onto
inner
circular
electrod
fluid
flow
transport
target
molecul
detect
antibodi
bulk
fluid
continu
suppli
target
molecul
ie
increas
affin
interact
onto
captur
domain
fluid
flow
tune
use
appli
ac
field
achiev
optim
fluid
flow
maxim
devic
perform
abil
acehd
flow
enabl
rapid
captur
detect
target
antigen
scfv
immobil
onto
acehd
devic
via
affin
tag
clone
scfv
acehd
field
appli
across
devic
result
flow
field
caus
target
collis
immobil
scfv
antigen
stool
sampl
remov
nonspecif
captur
protein
molecul
secondari
quantumdotlabel
detect
antibodi
use
detect
captur
target
antigen
devic
imag
confoc
microscop
obtain
fluoresc
imag
detect
antigen
figur
first
demonstr
combin
acehd
facilit
rapid
captur
antigen
remov
nonspecif
bound
molecul
detect
remain
bound
antigen
within
min
furthermor
sensit
limit
detect
antigen
captur
improv
fg
ml
structur
character
reveal
optim
yeast
fragment
size
protein
captur
nm
electrochem
sensor
limit
like
due
larger
size
yeast
fragment
exert
forc
solut
detach
biosensor
possibl
larger
fragment
may
also
result
nonspecif
absorpt
yeast
cell
wall
yeast
fragment
size
simpli
control
use
syringedriven
size
filter
unit
cell
wall
fragment
provid
advantag
gener
quicker
cheaper
ad
stabil
may
limit
vitro
diagnost
applic
effect
vivo
yet
investig
possibl
yeast
cell
wall
fragment
could
elicit
immun
respons
introduc
host
exampl
recombin
nonpathogen
saccharomyc
cerevisia
cerevisia
base
vaccin
use
number
tumor
pathogen
drive
innat
immun
vaccin
antigen
found
yeast
cell
wall
act
inher
adjuv
activ
dendrit
cell
turn
elicit
robust
immun
respons
compris
yeast
cell
wall
fragment
may
also
potenti
use
adjuv
vaccin
although
cell
wall
fragment
rel
easi
gener
heterogen
respect
size
batch
batch
variat
display
scfv
could
pose
potenti
problem
produc
fragment
reliabl
display
scfv
yeast
surfac
homogen
result
section
yeast
cell
wall
display
scfv
select
current
method
overcom
issu
use
affin
purif
step
captur
fragment
virtu
interact
antiha
antibodi
ha
affin
tag
clone
yeastdisplay
scfv
ensur
activ
conjug
onto
immunosensor
allow
specif
captur
target
antigen
current
experi
indic
fragment
consist
fragment
leav
associ
scfv
stabl
activ
protein
captur
affin
reagent
typic
purifi
antibodi
trade
ad
time
expens
pure
affin
reagent
biosensor
applic
wholecel
biosensor
develop
display
enzym
xylos
dehydrogenas
xdh
glucos
dehydrogenas
maltos
organophosphoru
hydrolas
oph
surfac
e
coli
anchor
enzym
microbi
cell
e
coli
elimin
need
enzym
purif
also
provid
stabil
display
enzym
enzym
display
e
coli
surfac
achiev
fusion
anchor
nucleat
protein
inp
fusion
e
coli
cell
wall
via
inp
found
increas
xdh
stabil
compar
cytoplasmicfre
xhd
improv
stabil
oph
compar
free
protein
electrochem
measur
carri
e
coli
biosensor
platform
high
sensit
good
specif
good
enzym
stabil
report
similar
approach
use
cerevisia
yeast
cell
aagglutinin
use
cell
wall
anchor
motif
benefit
use
yeast
cell
compar
e
coli
eukaryot
yeast
cell
display
properli
fold
protein
due
presenc
chaperon
glucos
oxidas
gox
recombinantli
express
surfac
whole
yeast
cell
goxyeast
conjug
carbon
nanotub
modifi
glassi
electrod
creat
wholecel
biosensor
glucos
cyclic
voltammogram
cv
use
determin
limit
detect
obtain
limit
detect
estim
glucos
spike
buffer
nm
determin
high
sensit
compar
gox
nanostructur
modifi
electrod
furthermor
also
demonstr
good
stabil
wide
ph
rang
ph
good
thermost
short
period
stabil
find
could
attribut
yeast
cell
wall
stabil
gox
vari
condit
filament
phage
particl
use
directli
biosensor
support
amino
acid
form
ntermin
major
coat
protein
pviii
phage
particl
modifi
display
billion
random
octapeptid
creat
landscap
librari
phage
particl
octapeptid
bind
protein
enzym
cell
tradit
phage
particl
landscap
phage
particl
select
success
round
biopan
toward
target
antigen
select
purifi
landscap
phage
could
immobil
onto
substrat
use
protein
captur
agent
detect
target
antigen
sandwich
elisa
system
use
whole
landscap
phage
directli
protein
captur
probe
method
retain
protein
bind
octapeptid
nativ
phage
wall
environ
reduc
time
complex
construct
biosensor
interestingli
remov
entir
coat
protein
wall
phage
particl
immobil
cell
wall
composit
substrat
enzym
binder
microarray
effect
sensit
keep
whole
landscap
phage
particl
intact
drop
sensit
could
attribut
isol
cell
coat
wall
lower
surfac
area
bind
enzym
compar
intact
sphericalshap
filament
landscap
phage
densiti
polypeptid
per
area
microarray
landscap
phage
surfac
found
greater
tradit
microarray
immobil
peptid
strategi
wholecel
landscap
phage
also
use
specif
captur
colorect
carcinoma
cell
onto
labelfre
ei
biosensor
landscap
phage
contain
copi
translat
recognit
site
multival
effect
achiev
target
whole
cell
cell
contain
mani
bind
site
across
surfac
result
increas
avid
affin
possibl
due
interact
thousand
recognit
site
landscap
phage
mani
bind
site
carcinoma
cell
applic
shown
phage
particl
mutat
bind
biomolecul
cell
interest
howev
given
filament
landscap
phage
particl
nm
length
nanomet
diamet
stringlik
dimens
particl
could
pose
problem
applic
micrometers
particl
could
interfer
biosensor
sensit
specif
furthermor
previou
work
shown
decreas
sensit
isol
cell
coat
protein
octapeptid
suggest
particl
effect
intact
nanometers
fragment
nonetheless
applic
demonstr
far
shown
landscap
phage
good
scope
screen
platform
biosens
interfac
demonstr
review
cell
envelop
composit
reagent
reliabl
gener
use
biosensor
global
challeng
futur
rapid
develop
diagnost
test
detect
infecti
diseas
better
infield
diagnost
requir
monitor
diseas
emerg
track
progress
diseas
throughout
popul
furthermor
emerg
diseas
human
past
sever
decad
result
transmitt
anim
human
zoonot
diseas
emerg
includ
recent
global
health
concern
regard
spread
ebola
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
coronaviru
merscov
although
concert
effort
organ
world
health
organ
deploy
diagnost
monitor
emerg
infecti
diseas
human
organ
monitor
diseas
emerg
anim
littl
done
connect
two
monitor
system
togeth
use
anim
sick
predict
human
dieas
addit
monitor
human
popul
health
earli
rapid
field
test
requir
enabl
health
care
task
forc
offici
scientist
monitor
potenti
animaltohuman
pathogen
current
approach
vaccin
drug
diagnost
develop
toward
infecti
diseas
shown
inadequ
yet
vaccin
ever
develop
time
chang
cours
outbreak
govern
agenc
call
flexibl
develop
product
platform
technolog
improv
r
readi
prioriti
infecti
diseas
threat
absolut
necess
novel
platform
technolog
wherebi
new
antibodi
rapidli
isol
incorpor
novel
assay
format
temperatur
solut
biosensor
surfac
stabl
reagent
need
seamlessli
incorpor
costeffect
diagnost
devic
distribut
easili
util
urban
rural
environ
review
describ
stateoftheart
technolog
achiev
goal
creat
nanostructur
compris
antibodi
compon
cell
wall
fragment
nanosc
cell
wall
fragment
antibodi
composit
structur
render
except
temperatur
storag
biosensor
applic
stabil
propos
integr
platform
technolog
figur
incorpor
rapid
isol
antibodi
use
yeast
display
follow
product
integr
devic
rapid
deploy
abil
rapidli
isol
antibodi
use
antibodi
display
librari
technolog
bacteriophag
bacteria
yeast
mammalian
cell
display
wellestablish
howev
success
techniqu
highli
depend
qualiti
antigen
present
librari
isol
antibodi
nativ
membran
protein
challeng
recent
develop
antibodi
librari
biopan
techniqu
util
whole
cell
ensur
recombin
membranebound
protein
maintain
nativ
conform
rel
exampl
success
cellbas
biopan
method
literatur
method
fail
overcom
limit
biopan
cell
surfac
name
low
target
densiti
high
background
irrelev
antigen
new
methodolog
use
transient
transfect
altern
host
cell
line
cho
hek
shown
figur
stringent
wash
step
allow
select
antibodi
membran
protein
nativ
conform
select
perform
scfv
stabil
util
previous
describ
format
new
approach
address
limit
optim
mani
cellbas
pan
method
allow
rapid
select
temperaturest
cell
diagnost
reagent
infecti
diseas
target
simplifi
pipelin
compar
tradit
mab
product
cell
envelop
composit
pair
rapid
biopan
method
address
product
time
concern
streamlin
requir
step
technolog
allow
rapid
develop
mab
toward
infecti
agent
matter
week
yeast
librari
select
incorpor
assay
figur
wholecel
biopan
use
librari
follow
simpl
method
scfv
stabil
product
power
platform
technolog
rapid
isol
product
affin
reagent
step
forward
address
limit
drug
diagnost
reagent
develop
develop
platform
rapidli
select
antibodi
pathogen
antigen
present
whole
cell
stabil
temperaturest
reagent
cell
envelop
use
pointofcar
diagnost
monitor
diseas
progress
anim
human
help
potenti
control
diseas
emerg
cell
envelop
composit
confer
stabil
protein
antibodi
fragment
maintain
nativ
nativelik
environ
protein
immunoassay
studi
nanodisc
biolog
nanoparticl
demonstr
great
util
provid
stabil
membran
protein
encapsul
protein
stabil
phospholipid
allow
membran
protein
remain
solut
henc
nativelik
environ
cellwallbas
composit
develop
respons
scfv
solubil
challeng
retain
nativ
yeast
cell
wall
environ
ie
semirigid
polysaccharid
lipid
protein
matrix
yeast
display
scfv
stabil
antibodi
fragment
use
diagnost
applic
screen
yeast
display
librari
facilit
rapid
isol
highaffin
scfv
binder
crucial
correctli
display
scfv
yeast
membran
surfac
way
scfv
kept
attach
yeast
cell
wall
allow
diagnost
agent
remain
environ
select
thu
provid
much
need
stabil
affin
binder
scfv
lyophil
longterm
storag
year
assay
directli
conduct
lyophil
agent
reduc
antibodi
product
time
howev
advanc
need
made
new
product
process
ensur
reagent
flexibl
sensit
stand
alongsid
mab
altern
diagnost
protein
captur
agent
current
lyophil
whole
insolubl
larg
mani
diagnost
applic
readout
method
also
limit
use
label
secondari
antibodi
address
limit
invent
design
new
diagnost
protein
captur
agent
use
immunosensor
diseas
biomark
novel
reagent
build
upon
work
advanc
whole
overcom
mani
limit
pose
technolog
small
solubl
agent
produc
use
varieti
molecular
biosens
platform
retain
stabil
quick
time
manufactur
lowcost
advantag
present
whole
togeth
advanc
cell
envelop
composit
demonstr
cellsurfac
protein
best
studi
util
nativ
environ
furthermor
cell
biopan
method
use
select
antibodi
toward
membran
protein
nativ
cell
environ
allow
product
highaffin
binder
cell
envelop
composit
could
develop
toward
biomolecul
requir
nativ
cell
environ
stabil
